HIV INFECTION

This study is testing whether starting powerful HIV medicines within 48 hours of birth can lead to long-term remission, meaning the virus stays undetectable even after stopping treatment. It will enroll over 1,100 infants born to mothers with HIV. The goal is to see if this very …

This early-stage study is testing a new oral medication called MK-4646 in people with HIV who have not yet started standard treatment. The main goals are to check if the drug is safe and well-tolerated, and to see if it can lower the amount of HIV virus in the blood. The study wi…

This study is testing two personalized treatment plans for anal cancer in people living with HIV. For patients with low-risk cancer, researchers are testing a reduced dose of chemotherapy and radiation to see if it's effective with fewer side effects. For patients with high-risk …

This early-stage study is testing a personalized immune therapy called axicabtagene ciloleucel (a type of CAR-T) for people with HIV who have an aggressive form of B-cell lymphoma that has returned or not responded to prior treatments. The main goals are to check if the treatment…

This study aims to find out if heart transplants from HIV-positive donors are as safe and work as well for HIV-positive recipients as transplants from HIV-negative donors. The research will follow 50 adults with both HIV and advanced heart failure who receive heart transplants, c…

This study aims to see if creating special HIV teams in hospitals can help find more people who have HIV but don't know it. The teams will work in hospitals across ten European countries, checking patient records for signs that might suggest HIV and encouraging doctors to offer t…

This study is testing a new at-home kit that checks for HIV and syphilis from a finger-prick of blood. Researchers want to see if people with no medical training can use it correctly and get accurate results. The study involves 900 people in Canada who are getting tested for thes…

This study is testing whether offering HIV prevention medication (PrEP) on a medical van is a practical way to reach people who use drugs and are at high risk for HIV. Researchers will enroll 20 adults who are active drug users and/or sexually active. The main goal is to see if t…

This study is testing whether a special smartphone app designed for people with HIV can help them quit smoking when it's used alongside a lung cancer screening scan. Researchers want to see if 100 participants will use the app and complete the scan, and if this combined approach …